Skip to content
ppharmaranks
Menu

Best treatments for acute promyelocytic leukemia

5 products may treat acute promyelocytic leukemia, spanning FDA drug classes such as retinoid. The current highest-rated option is retin-a. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 5 drugs we list for acute promyelocytic leukemia, 4 are available as lower-cost generics, spanning classes such as retinoid. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for acute promyelocytic leukemia — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top-rated picks for acute promyelocytic leukemia: 1. Retin-A · 2. Tretinoin · 3. Atralin

Top-rated treatments for acute promyelocytic leukemia, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$1View →
268/100$1View →
3Not yet rated$1View →
4Not yet rated$1View →
5Not yet ratedView →

Narrow by drug class

Explore the class hubs: retinoid

Full ranking · 5 treatments

Frequently asked

What treats acute promyelocytic leukemia?
Our catalog lists 5 products that may treat acute promyelocytic leukemia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is retin-a.
What is the best-rated treatment for acute promyelocytic leukemia?
By our independent recall-safety rating — not an efficacy measure — retin-a ranks highest among the products we list for acute promyelocytic leukemia. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat acute promyelocytic leukemia?
Treatments for acute promyelocytic leukemia span FDA drug classes including retinoid. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.